Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (33)

2024

  1. Anti-retinal Antibodies in Sarcoidosis

    Ocular Immunology and Inflammation, Vol. 32, Núm. 2, pp. 141-147

  2. Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings

    Ocular Immunology and Inflammation

  3. Posner-Schlossman Syndrome European Study Group: study protocol and baseline patients characteristics of a multicentre study

    British Journal of Ophthalmology

2023

  1. Herpetic Anterior Uveitis Multicentre Longitudinal Study (The UVHER Project). Baseline Characteristics

    Ocular Immunology and Inflammation, Vol. 31, Núm. 7, pp. 1497-1504

  2. The retinal bacillary layer detachment: Clinical features and outcomes in posterior uveitis

    Journal Francais d'Ophtalmologie, Vol. 46, Núm. 8, pp. 916-920

2022

  1. Guía de recomendaciones para el manejo de brolucizumab

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 11, pp. 626-638

  2. Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients

    Clinical and Experimental Rheumatology

  3. Ischemic Optic Neuropathy After Administration of a SARS-CoV-2 Vaccine: A Report of 2 Cases

    American Journal of Case Reports, Vol. 23, Núm. 1

2021

  1. Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 7, pp. 347-352

  2. Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group

    Revista Clinica Espanola, Vol. 221, Núm. 4, pp. 221-225

2020

  1. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

    Ophthalmology

  2. Standardization of Nomenclature for Ocular Tuberculosis–Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

    Ocular Immunology and Inflammation, Vol. 28, Núm. sup1, pp. 74-84

  3. The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings

    Ocular Immunology and Inflammation, Vol. 28, Núm. sup1, pp. 85-95

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  2. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2381-2390

2018

  1. Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro

    PLoS ONE, Vol. 13, Núm. 11

  2. Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

    Journal of Ophthalmology, Vol. 2018

2017

  1. Telemedicine for a General Screening of Retinal Disease Using Nonmydriatic Fundus Cameras in Optometry Centers: Three-Year Results

    Telemedicine and e-Health, Vol. 23, Núm. 1, pp. 30-36

2016

  1. Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis

    Journal of Ophthalmic Inflammation and Infection, Vol. 6, Núm. 1

2015

  1. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 3, pp. 361-368